All Cosmos Bio-Tech Holding Corporation (4148.TW) TAI

Currency In TWD

AD

Valuation

Market Cap3.46B
Enterprise Value2.62B
P/E Ratio11.42
PEG Ratio0.43
Price/Sales Ratio0.67
Price/Book Ratio0.94
Enterprise/Revenue0.5
Enterprise/EBITDA4.03

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.06
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue2.95B
Revenue/Share38.59
Gross Profit829.47M
EBITDA362.56M
Net Income153M
Diluted EPS2.28

Balance Sheet

Total Cash1.42B
Total Cash/Share17.26
Total Debt612.75M
Total Debt/Equity0.22
Current Ratio3.86
Book Value Per Share42.59

Price History

52-Week Change-19.33
52-Week High44.9
52-Week Low29.25
Moving Average 50 Days31.95
Moving Average 200 Days35.05

Statistics

Average Volume49,294
Shares Outstanding67.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield3.17
Payout Ratio0.17
Last Split Factor21:20
Last Split DateAugust 14, 2025
AD